What each compound is, and where it appears in the research literature. Every entry links through to its full specification.
A synthetic pentadecapeptide — fifteen amino acids — derived from a partial sequence of a protein found in gastric juice. Stable in aqueous solution and one of the most frequently referenced compounds in the preclinical peptide literature.
A synthetic version of the active region of Thymosin Beta-4, a naturally occurring 43-amino-acid protein. Supplied as the shorter, water-soluble fragment used in laboratory work.
A synthetic analogue of growth-hormone-releasing hormone (GHRH), modified at four positions for stability. The No-DAC form — also referenced as Mod GRF 1-29 — omits the drug-affinity complex.
A selective pentapeptide agonist of the ghrelin receptor (GHS-R). Noted in the literature for its selectivity relative to earlier growth-hormone secretagogues.
A synthetic 44-amino-acid analogue of human growth-hormone-releasing hormone, stabilised with a trans-3-hexenoyl group at the N-terminus.
A synthetic triple receptor agonist targeting the GLP-1, GIP and glucagon receptors — the most recent of the incretin-class research compounds.
A synthetic GLP-1 receptor agonist carrying a fatty-acid side chain that extends its half-life. One of the most extensively characterised incretin analogues.
A synthetic dual agonist of the GIP and GLP-1 receptors, built on a 39-amino-acid backbone.
A synthetic tetrapeptide (Ala-Glu-Asp-Gly) based on a sequence isolated from the pineal gland.
Nicotinamide adenine dinucleotide — a coenzyme present in all living cells and central to redox reactions. Supplied as a lyophilized powder; not a peptide.
A 16-amino-acid mitochondrial-derived peptide, encoded in mitochondrial rather than nuclear DNA.
A naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper(II). Takes on a distinctive deep blue colour in solution.
A synthetic heptapeptide analogue of tuftsin, an endogenous immunomodulatory peptide, with an added stabilising tripeptide.
A synthetic heptapeptide based on the ACTH(4-10) fragment, extended at the C-terminus with Pro-Gly-Pro for stability.
A co-supplied preparation of BPC-157 and TB-500 in equal parts — the most frequently paired combination in tissue-model research.
BPC-157 + TB-500
A three-compound preparation of GHK-Cu, BPC-157 and TB-500, co-supplied in a single vial.
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg
A four-compound preparation adding KPV — a tripeptide fragment of α-MSH — to the GLOW combination.
GHK-Cu 50 mg + BPC-157 10 mg + TB-500 10 mg + KPV 10 mg
A co-supplied preparation of CJC-1295 (No DAC) and Ipamorelin in equal parts — a GHRH analogue paired with a selective ghrelin-receptor agonist.
CJC-1295 5 mg + Ipamorelin 5 mg
Vial amount and diluent in, concentration and syringe volume out. Arithmetic only.
For research use only · Not intended for human consumption
